John, this morning. listening to and Thanks welcome everyone
the While sales our we’ll performance few John safety color give and in of you of performance the year, fiscal minutes, for has the behind next quarter those the food I and discussing first profit start overall will reported the group. some by results
We do operate fluctuations impacted be continue to we currencies by in countries in the in.
As in $X.X have the revenues john environment. for higher been million would mentioned, neutral currency quarter a
each down with the Pound stand-off the declined Euro result X%, X% the And Aussie to Brexit in safety the dollar declined U.S., report of uncertainty, the as $X of the of the this in through and largely down X% trade the the With million continuing in majority RMB the due about the X% part segment businesses in food is shortfall and international the segment. that quarter. Chinese
quarter. The other there Revenues that's first our impacted the overall segment, our of compared million million currency the food and international quarter safety issues issues of fiscal affected XXXX, to in also in last but $XX.X X% were $XX within a businesses were segment first which results. decrease for year's the
we the And in corn in continued commercial XX% led Brazil in the insecticide government result a two items gains for I safety These harvest, sale method products decline about offset increase gains a country's had a antibiotic agency year's Brazil in during sales first market and $X in approximately quarter. XX% of a sales test impact $XXX,XXX the diagnostic we quarter. in to customer drivers amount in nonrecurring million lost quarter, the each the that an quarters lab dairy in a had noted discussed, aflatoxin changed drugs third a overall quarter. that and and operations current Brazilian food by lesser by in sales testing. The commercial as as second testing higher to was for large forensic the last fourth increase and in lost a kit will Our sales share sales, but quarter, throughput in customer XX%
products revenues, operations media culture XXXX relatively partially in declined large These a sluggish in After in the the X% quarter. our U.S. which the and the X% our had in on year, increases in clean crops year's operations by were outbreak prior sale revenues England-based a the the spoilage for European Genomics first last revenues, declines Our disinfectant year. pace organisms quarter, this X% mild a lower quarter quarter strength of results of increase currency, detect grew up year a first last with revenues double-digit France. local cleaner in of the business. primarily and European for sales by throughout to DON after XX% rose offset first of dollars, to in converting equipment due at to for quarter X%
this our in sales lower in from overall rodenticides of Neogen resulted to cleaners, aflatoxin food due in larger and to disinfectants, XX% of group. products strong due an dropped customers for lines. Latinoamerica, and our the revenues quarter business safety had and an the large diagnostic distributors, product led and X% in however this demand increase in corn across outbreak orders in of rose part Sales of City, Mexico. delayed XX%, growth for by sales Sales all in Mexico based broadly mycotoxin kit
lower in revenue which Our were to fever genomic resulted impacted that an testing in China. XX% pork China swine for and African operations in the decline by contributed negatively the quarter outbreak in in in country,
for some our grew up X% detect test there areas period. and sales quarter peanuts, nut the determine business. XX% which by milk, for the the diagnostic among and particularly but tests processed respectively were allergen gliadin to Revenues kit Our strong, up domestic of presence quarter. nice business growth soy, XX% inadvertent food and the were in industry-leading domestically of the were to Tree within line safety others, only product includes contamination, XX% for
added and tests such allergen recently We coconut. to kit test contaminants new have continued strengthen for portfolio our as
is Our strong AccuPoint in quarter. cleanliness increase a sample XX% processing used during line, food in disposable and detect to the sanitation general revenues environments, which had
believe the X% by quarters. and the an last crops of sales natural Our quarter to other year's as product domestic mature, these weather, grains planting severe third compared due harvest and we first crops. decreased late caused will corn to toxin second has uptick in new the in which this part spring the in of see We that delayed the
by antibiotics primarily to due distributor. test demand the declined in for quarter, to from Revenues X% our in presence detect the large lower European a of milk
Our production, our weakness domestic the for quarter. culture pushed those A markets. particularly their due animal to media the vaccine number business products these year of the customers, orders of quarter to their in have second and in declined half XX% in second larger
quarter. we to sales Finally, mold unable reader in to ship suppliers. second readers of readers to our a number organisms key part for These backorders This to shortfall of the were as one line of in yeast with ship approximately our expected and in product for spoilage due the are quarter. $XXX,XXX a such detect resulted equipment
safety between disrupted U.S. segment ongoing animal trade which the has China, adversely and by impasse market. continues The impacted to our the be
a recorded over with quarter. first X% animal in increase strength domestic by and achieved we the last This $XX.X in the year's was market bioinformatics wellness million of testing in gains genomics commercial continued dairy share in cattle However, revenues parentage located Nebraska up and driven service $XX.X growth Lincoln, companion our for beef the XX% and business quarter, million with markets. in and testing the revenue markets
growth of as manufacturing genomics rose rose instruments and as X% distribution Worldwide, wound antibiotics our in Lexington, were Kentucky-based products vet and syringes disposable quarter. for Brazil, up and marketing center XX% revenues by such out in sales Canada and animal with the XX% lower Australia care sold Animal small China. such supplements, products additional care, offset
gains and primarily and quarter. X% offset commercial to promotional pressure the more kit science country. life rose lower and sales declined these in in forensic essentially flat Rodenticide cleaner disinfectant certain sales And rodent of were labs the areas sales Now of domestic insecticides in to of the were partially lower rebates. by the higher quarter due X% result products, sales
XX.X% the and animal in products XX.X% products. here year's last to biosecurity last segment lower the in quarter. and margin due year's media our food toward The such quarter Gross on genomics and first segment domestic rose the margins is operating improvement shift to lower operation to first margins the for of in products which our safety quarter in quarter. compared increased X% have expenses culture as safety compared Overall, were mix higher the margins at gross product sales
depreciation which quarter. development $X.X technology stock-based rate the XXXX quarter early the over expenses General due X% to be number administrative products $XXX,XXX of increased to spent fiscal we this run expect expenses our quarter, in X%, to investments and XX% the Research expenses primarily infrastructure, continued and revenue marketing with fees. resulting expenses year information line in for growth prior higher and or legal from increased as development increased rose for the we late million similar a XXXX. is in are we $X.X we and new And The XXXX. and compensation in quarter scheduled continue throughout XXXX. the continue to fiscal on launched spending fiscal million last of spent this Sales
to year's last year. was and quarter. $XX.X This in with compared higher balances R&D to the interest compared expressed XX.X% on result level. higher million first recorded percent quarter and the revenues, year, last of the interest higher last compared We as first the decline for to of And was income in operating reflects million in $XXX,XXX those balances. million, a $XX.X $X.X XX% exactly income for marketable Operating income securities our quarter rates spending cash the
in in losses the year. last compares totaling $XXX,XXX $XXX,XXX to the same currency in losses quarter first period Foreign
XX.X% unusually comparable rate $X.X compared to last was quarter. from year, in effective exercise million million XX% was first in the quarter low number $XX.X to the recognized Our for first due option. pretax our stock to $XXX,XXX. in effective million tax was year's first profit This And of $XX.X Last compared rate was tax the quarter. year's last year's benefits
rate the As I effective of previous calls, periods. option on comparative in in exercises the volume the mentioned for have result large tax fluctuations can
for the our sheet, our X% balance was balance compared first increased quarter. million to XX by period declined days the On X%. end or year and Inventory receivables $X.X collection by net
significant to additional invested this and license focusing have to $XX.X operation property, technology. million are at million inventory $X of operations turns the year happen. during generated We place that programs quarter, and equipment each make from effort in amounts our in and on plant and that objectives cash improving We in
business which need I we market business. the one-time that areas we There that will were factors well growth organic of the other to the performed stop realize say our number here and by of accelerate performances obscured in in were which quarter, to noise.
continue be of about support. appreciate remainder year excited the the We to and your
it this John point, turn further for to at And comments. will back I
